{
    "2020-10-30": [
        [
            {
                "time": "2020-10-30",
                "original_text": "【天风医药】药明康德：三季度收入加速增长，中国区实验室服务和CDMO板块表现卓越",
                "features": {
                    "keywords": [
                        "药明康德",
                        "三季度",
                        "收入增长",
                        "实验室服务",
                        "CDMO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-30",
                "original_text": "【天风医药】老百姓：三季度业绩略超预期，四架马车助力扩张",
                "features": {
                    "keywords": [
                        "老百姓",
                        "三季度",
                        "业绩超预期",
                        "扩张"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-10-30",
                "original_text": "恒瑞医药遭沪股通连续7日净卖出合计净卖出11.38亿元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "沪股通",
                        "净卖出"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-30",
                "original_text": "基金减持恒瑞医药和长春高新 减持股份",
                "features": {
                    "keywords": [
                        "基金",
                        "减持",
                        "恒瑞医药",
                        "长春高新"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-30",
                "original_text": "A股融资融券日报：两融余额增加46.35亿元（10月29日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-30",
                "original_text": "中金 | 公募基金三季报回顾：基金仓位配置更加均衡",
                "features": {
                    "keywords": [
                        "公募基金",
                        "三季报",
                        "仓位配置",
                        "均衡"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}